AAAAAA
Results: 26-50/54
Authors:
Stahl, SM
Citation: Sm. Stahl, Blue genes and the mechanism of action of antidepressants, J CLIN PSY, 61(3), 2000, pp. 164-165
Authors:
Stahl, SM
Citation: Sm. Stahl, Blue genes and the monoamine hypothesis of depression, J CLIN PSY, 61(2), 2000, pp. 77-78
Authors:
Stahl, SM
Citation: Sm. Stahl, New drug discovery in the postgenomic era: From genomics to proteomics, J CLIN PSY, 61(12), 2000, pp. 894-895
Authors:
Stahl, SM
Citation: Sm. Stahl, The new cholinesterase inhibitors for Alzheimer's disease, part 2 - Illustrating their mechanisms of action, J CLIN PSY, 61(11), 2000, pp. 813-814
The new cholinesterase inhibitors for Alzheimer's disease, Part 1 - Their similarities are different
Authors:
Stahl, SM
Citation: Sm. Stahl, The new cholinesterase inhibitors for Alzheimer's disease, Part 1 - Their similarities are different, J CLIN PSY, 61(10), 2000, pp. 710-711
Authors:
Stahl, SM
Citation: Sm. Stahl, Molecular neurobiology for practicing psychiatrists, part 5: How a leucinezipper can turn on genes: immediate-early genes activate late-gene expression in the brain, J CLIN PSY, 61(1), 2000, pp. 7-8
Authors:
Stahl, SM
Citation: Sm. Stahl, Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline, BIOL PSYCHI, 48(9), 2000, pp. 894-901
Authors:
Ory, MG
Lipman, PD
Barr, R
Harden, JT
Stahl, SM
Citation: Mg. Ory et al., A national program to enhance research on minority aging and health promotion, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, 2000, pp. 9-18
Authors:
Shayegan, DK
Stahl, SM
Citation: Dk. Shayegan et Sm. Stahl, Buspirone, MIL DRUG TH, 2000, pp. 13-25
Authors:
Stahl, SM
Citation: Sm. Stahl, Molecular neurobiology for practicing psychiatrists, Part 1: Overview of gene activation by neurotransmitters, J CLIN PSY, 60(9), 1999, pp. 572-573
Authors:
Stahl, SM
Citation: Sm. Stahl, Antipsychotic polypharmacy, part 2: Tips on use and misuse, J CLIN PSY, 60(8), 1999, pp. 506-507
Authors:
Stahl, SM
Citation: Sm. Stahl, Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?, J CLIN PSY, 60(7), 1999, pp. 425-426
Authors:
Stahl, SM
Citation: Sm. Stahl, Antidepressants: The blue-chip psychotropic for the modern treatment of anxiety disorders, J CLIN PSY, 60(6), 1999, pp. 356-357
Mergers and acquisitions among psychotropics: Antidepressant takeover of anxiety may now be complete
Authors:
Stahl, SM
Citation: Sm. Stahl, Mergers and acquisitions among psychotropics: Antidepressant takeover of anxiety may now be complete, J CLIN PSY, 60(5), 1999, pp. 282-283
Authors:
Stahl, SM
Citation: Sm. Stahl, Why settle for silver, when you can go for Gold? Response vs. recovery as the goal of antidepressant therapy, J CLIN PSY, 60(4), 1999, pp. 213-214
Authors:
Stahl, SM
Citation: Sm. Stahl, Peptides and psychiatry, part 3: Substance P and serendipity: Novel psychotropics are a possibility, J CLIN PSY, 60(3), 1999, pp. 140-141
Authors:
Stahl, SM
Citation: Sm. Stahl, Substance P and the neurokinins: Novel peptide neurotransmitters in psychopharmacology, J CLIN PSY, 60(2), 1999, pp. 77-78
Authors:
Stahl, SM
Citation: Sm. Stahl, Molecular neurobiology for practicing psychiatrists, part 4: Transferring the message of chemical neurotransmission from presynaptic neurotransmitterto postsynaptic gene expression, J CLIN PSY, 60(12), 1999, pp. 813-814
Authors:
Stahl, SM
Citation: Sm. Stahl, Molecular neurobiology for practicing psychiatrists, Part 3: How second messengers "turn on" genes by activating protein kinases and transcription factors, J CLIN PSY, 60(11), 1999, pp. 731-732
Authors:
Stahl, SM
Citation: Sm. Stahl, Molecular neurobiology for practicing psychiatrists, Part 2: How neurotransmitters activate second messenger systems, J CLIN PSY, 60(10), 1999, pp. 647-648
Authors:
Stahl, SM
Citation: Sm. Stahl, Relative weight gain among antipsychotics - Reply, J CLIN PSY, 60(10), 1999, pp. 707-708
Authors:
Stahl, SM
Citation: Sm. Stahl, Introduction - What makes an antipsychotic atypical?, J CLIN PSY, 60, 1999, pp. 3-4
Authors:
Stahl, SM
Citation: Sm. Stahl, Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials, J CLIN PSY, 60, 1999, pp. 31-41
Authors:
Stahl, SM
Citation: Sm. Stahl, Peptides and psychiatry, part 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis, J CLIN PSY, 60(1), 1999, pp. 5-6
Authors:
Settle, EC
Stahl, SM
Batey, SR
Johnston, JA
Ascher, JA
Citation: Ec. Settle et al., Safety profile of sustained-release bupropion in depression: Results of three clinical trials, CLIN THER, 21(3), 1999, pp. 454-463